Autoanti-D in a patient after cladribine treatment for lymphoplasmocytic lymphoma Cover

.blurhash-client-img { display: none !important; }

Autoanti-D in a patient after cladribine treatment for lymphoplasmocytic lymphoma

Immunohematology

Volume 18 (2002): Issue 1 (March 2002)

By: J. Cid, V. Beltran, L. Escoda, E. Elies and C. Martin-Vega

Paid access

|Oct 2020

Authors

J. Cid

Centre de Transfusió I Banc de Teixits C/. Dr. Mallafré Guasch, Tarragona, Spain

V. Beltran

Haematology Service, Hospital Joan XXIII, Tarragona, Spain

L. Escoda

Centre de Transfusió I Banc de Teixits, Tarragona, Spain

E. Elies

Centre de Transfusió I Banc de Teixits, Tarragona, Spain

C. Martin-Vega

Centre de Transfusió I Banc de Teixits, Tarragona, Spain

DOI: https://doi.org/10.21307/immunohematology-2019-499 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X

Journal RSS Feed

Language: English

Page range: 16 - 18

Published on: Oct 14, 2020

Published by: American National Red Cross

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

direct antiglobulin test,

anti-D in a D+ recipient

Related subjects:

Clinical medicine,

Laboratory medicine

© 2020 J. Cid, V. Beltran, L. Escoda, E. Elies, C. Martin-Vega, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous article Volume 18 (2002): Issue 1 (March 2002)Next article